Kuros Biosciences AG (KURN) — Capital Reinvestment Ratio
Kuros Biosciences AG (KURN) has a Capital Reinvestment Ratio of 0.53x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF1.94 Million) in capital expenditures (CHF1.03 Million). See KURN net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kuros Biosciences AG Capital Reinvestment Ratio (2024–2024)
This chart tracks Kuros Biosciences AG's Capital Reinvestment Ratio across 1 annual periods. Check KURN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kuros Biosciences AG (2024–2024)
Year-by-year Capital Reinvestment Ratio for Kuros Biosciences AG from 2024 to 2024. For live market cap and broader valuation context, see Kuros Biosciences AG (KURN) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | CHF3.14 Million | CHF1.11 Million | — |